de Quervian’s Tenosynovitis De Quervain’s tenosynovitis,
Conditions
Interventions
1 mL ketorolac 30 mg/mL + 0.5 mL 1% lidocaine with adrenaline,1 ml triamcinolonacetonide
10 mg/ml + 0.5 mL 1% xylocaine with adrenaline
Experimental Drug,Active Comparator Drug
Ketorolac injection,Triamcinolone Acetonide Injection
Sponsors
None
Eligibility
Sex/Gender
All
Age
20 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 20 years old 2. The patients will require to have all of the following two physical findings: 2.1 Radial styloid tenderness 2.2 Pain at the radial wrist with resisted extension or abduction of the thumb 2.3 Positive Finkelstein’s test or WHAT test.
Exclusion criteria
Exclusion criteria: 1 Patients who allergy to NSAIDs or same group of ketorolac (e.g. diclofenac) 2 History of severe complication from corticosteroid injection or ketololac injection including anaphylaxis 3 Prior treatment in the last six months with steroid injection and/or surgery at the same anatomical location. 4 Possible traumatic or neoplastic origin of symptoms 5 Patient had inflammatory joint disease at the affected wrist. 6 Inability to fill in follow-up forms or absence of self determination in the participant patient. 7 Patients with pre-existing condition with high risk of drug AE (e.g. ketorolac related to platelet dysfunction) 8 Patient who participate another research in the same time of this project
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment successfull at the 6 weeks post injection all three physical signs will completely resolve resolve and the patient has at least 90% improvemen | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score before injection date and at the 6 weeks post injection a visual numerical rating scale, with 0 indicating no pain and 10 indicating extremely intense pain | — |
Contacts
Public ContactSITTHIPHONG SUWANNAPHISIT
Faculty of Medicine, Prince of Songkla University,
Outcome results
None listed